tiprankstipranks
Immunome (IMNM)
NASDAQ:IMNM
US Market

Immunome (IMNM) Financial Statements

183 Followers

Immunome Financial Overview

Immunome's market cap is currently ―. The company's EPS TTM is $-7.544; its P/E ratio is -1.85; Immunome is scheduled to report earnings on August 15, 2024, and the estimated EPS forecast is $-0.37. See an overview of income statement, balance sheet, and cash flow financials.
Mar 24Dec 23Sep 23Jun 23Mar 23
Income Statement-
Total Revenue$ 1.03M$ 3.83M$ 3.56M$ 4.26M$ 2.36M
Gross Profit$ 1.03M$ 3.83M$ 3.56M$ 4.26M$ 2.36M
EBIT$ -20.34M$ -13.85M$ -4.63M$ -5.77M$ -4.47M
EBITDA$ -20.08M$ -13.59M-$ -5.62M$ -4.32M
Net Income Common Stockholders$ -129.49M$ -92.63M$ -4.34M$ -5.56M$ -4.27M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 309.70M$ 138.14M$ 90.64M$ 38.42M$ 44.42M
Total Assets$ 319.75M$ 148.54M$ 93.16M$ 41.44M$ 48.11M
Total Debt$ 1.21M$ 0.00$ 0.00$ 0.00$ 0.00
Net Debt$ -308.49M$ -138.14M$ -90.64M$ -38.42M$ -44.42M
Total Liabilities$ 34.18M$ 28.66M$ 87.08M$ 32.10M$ 34.25M
Stockholders Equity$ 285.57M$ 119.88M$ 6.08M$ 9.37M$ 13.86M
Cash Flow-
Free Cash Flow$ -28.34M$ -17.81M-$ -6.01M$ 24.07M
Operating Cash Flow$ -11.17M$ -17.46M$ -8.61M$ -5.67M$ 24.17M
Investing Cash Flow$ -37.23M$ -30.00M$ -36.00K$ -340.00K$ -106.00K
Financing Cash Flow$ 219.44M$ 55.50M$ 60.88M-$ 34.00K
Currency in USD

Immunome Earnings and Revenue History

Immunome Debt to Assets

Immunome Cash Flow

Immunome Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis